{
  "id": "8c63dee02a1bb324c9a217034e094a0b33c2fe66",
  "title": "Ozempic for type 2 dibates: Weight loss observed in many patients but not approved for all",
  "summary": "For anyone who overindulged during the holidays, the hype around weight-loss drugs like Ozempic can be tempting. Originally developed to treat diabetes, the medication suppresses appetite—and in the U.S., where oversized portions and fast food reign, its effects are even noticeable in New York restaurants. Doctor Emmanuelle Lecornet-Sokol, endrocrinologist…",
  "canonicalUrl": "https://www.france24.com/en/video/20251226-ozempic-for-type-2-dibates-weight-loss-observed-in-many-patients-but-not-approved-for-all",
  "source": {
    "id": "france24_all",
    "name": "France 24 - Top Stories",
    "url": "https://www.france24.com/en/",
    "feedUrl": "https://www.france24.com/en/rss",
    "country": "FR",
    "language": "en"
  },
  "publishedAt": "2025-12-26T14:00:45.000Z",
  "fetchedAt": "2025-12-26T14:23:12.093Z",
  "category": "world",
  "tags": [
    ""
  ],
  "image": "https://s.france24.com/media/display/e7bc63de-e262-11f0-afe3-005056a90284/w:1024/p:16x9/EN-20251226-131511-132138-CS.jpg",
  "language": "en",
  "storagePath": "data/articles/world/2025/12/26/8c63dee02a1bb324c9a217034e094a0b33c2fe66.json",
  "contentText": "For anyone who overindulged during the holidays, the hype around weight-loss drugs like Ozempic can be tempting. Originally developed to treat diabetes, the medication suppresses appetite—and in the U.S., where oversized portions and fast food reign, its effects are even noticeable in New York restaurants. Doctor Emmanuelle Lecornet-Sokol, endrocrinologist and President of Fenarediam in Paris, explains.",
  "contentSource": "content"
}
